Nightingale Health Oyj B
The answer first
Does Nightingale Health beat the market?
No, Nightingale Health has not beaten the market over the last year.
The ranking · Quality, value and trend combined
Better than 51% of Nordic stocks
- Quality75
- Value8
- Trend76
No. 58 of 195 in healthcare
Max for seven days
Follow Nightingale Health with AuroraAurora lets you know at the next report. No card.
Both with dividends. Figures as of 20 November 2026. General analysis, not personal advice.
Follow your thesis
Ask Aurora about Nightingale Health
Your first answer is free, no account needed.
Do you own Nightingale Health, or are you thinking about it?
See it next to the rest of your portfolio, or build your first one with Nightingale Health and a few more. Free, no card.
Super Stock+45.3%In short
- Nightingale Health has fallen 23.8% over the past year, including dividends.
- Overall, Nightingale Health ranks better than 51% of Nordic stocks on quality, value and trend.
- The largest fall over the past three years was 84.6%. The price is 73.2% below its peak now.
Who owns Nightingale Health? See the major shareholders and their stakes
What do analysts think of Nightingale Health?
Quality, value and trend
Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.
Quality, value and trend together. Better than 51% of Nordic stocks.
No. 58 of 195 in healthcare
High A solid company: it earns well on its money and has healthy finances.
No. 72 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50
- Debt to equityBorrowings divided by equity0.16
- Asset turnoverSales divided by everything the company owns0.08
- Return on equityProfit divided by equity−39.1%
- Cash conversionOperating cash flow divided by profit–
The ranking is built on equity ratio, ROA and how steadily profit grows.
Low High price: buyers pay a lot today, often because they expect growth.
No. 145 of 197 in healthcareTypical in healthcare: 19Typical in the Nordics: 50
- P/BPrice divided by equity2.1
- P/SPrice divided by sales20.9
- P/EPrice divided by earningsnegative earnings
- P/CFPrice divided by operating cash flownegative earnings
The ranking is built on P/E, P/B and P/S.
High Tailwind in the share price: it has risen more than most over the last year.
No. 48 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50
- 3 months+86.4%
- 6 months+98.9%
- 9 months+13.5%
- 12 months−23.8%
The ranking is built on 3, 6 and 12–1 months.
Return and risk
Return with dividends reinvested.
About Nightingale Health
Nightingale Health Oyj B is a company in healthcare, listed on Nasdaq Helsinki. By market value, Nightingale Health is number 7 of 16 companies in healthcare on Nasdaq Helsinki. Nightingale Health has not paid a dividend in the past twelve months. Of the three measures in the ranking, Nightingale Health is strongest on trend, better than 76% of Nordic stocks. The share trades in EUR. It has around 100 employees.
Nightingale Health Oyj, a health technology company, offers advanced health check that detects disease risks in Finland, Europe, the Middle East, Africa, AMER, and the Asia-Pacific. The company's Health Check that detects the risks associated with various common chronic diseases from a single blood sample; and Remote Health Check where health check done remotely, as well as multiomics analysis services. It provides its services to research programs, universities, and healthcare providers. The company has a collaboration with Personalised Health Clinics to incorporate the company's metabolomic blood testing into Personalised Health Clinics' personalized, clinician-led healthcare services.


See the full analysis of Nightingale Health.
The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.
Free forever · No card